Takeda Pharmaceutical TAK
NYSE TAK
$18.20 -0.14 (-0.76%)
At close: Aug 20, 2026 · 1:00 PM UTC

Takeda Pharmaceutical (TAK) Net Income Growth (3y) (2020 - 2026)

Takeda Pharmaceutical (TAK) Net Income Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn 14.04%
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -27.09%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 8.71%
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -34.81%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 14.78%
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 36.74%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -86.97%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.33%
Mar 31, 2026 -4.58%
Dec 31, 2025 -93.32%
Sep 30, 2025 78.55%
Jun 30, 2025 -8.42%
Mar 31, 2025 -22.02%
Dec 31, 2024 -49.05%
Sep 30, 2024 50.26%
Jun 30, 2024 -25.96%
Mar 31, 2024 15.49%
Dec 31, 2023 -73.36%
Sep 30, 2023 158.29%
Jun 30, 2023 -7.31%
Mar 31, 2023 -18.06%
Sep 30, 2022 59.22%
Jun 30, 2022 136.74%
Mar 31, 2022 144,003.41%
Dec 31, 2021 14.42%
Sep 30, 2021 96,851.79%
Jun 30, 2021 40.94%